C/ base no CPA 2023_368 - cloro-hexidina 0.2% gel bucal bisn 40 ml
TED · 621759-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de cloro-hexidina 0.2% gel bucal bisn 40 ml
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-09 | C/ BASE NO CPA 2023_481 - AXICABTAGENE CILOLEUCEL 0.4 - 2 X10E8 CÉLULAS DISP INJ FR 68 ML IV | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-08 | C/ BASE NO CPA 2025_1303 - OCRELIZUMAB 920 MG/23 ML SOL INJ FR 23 ML SC | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-14 | Com base no cpa 2025_1303 - Glofitamab - justificação clinica | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-28 | C/ BASE NO CPA 2026_6 | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-09 | C/ base no CPA 2023_671 - Foslevodopa 240 mg/ml + Foscarbidopa 12 mg/ml sol inj fr 10 ml sc | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-26 | C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP + TEPOTINIB 225 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 93% |